This Week in Psychedelics - 11.19.21

Cannabis

• U.S. Republicans move to decriminalize marijuana at federal level (Reuters)

• Germany Set To Legalize Marijuana Nationwide After Major Parties Reach Agreement (Marijuana Moment)

• Brazil is on The Brink of Medical Cannabis Change (High Times)

• Is This The First Real Case Of Fentanyl-Tainted Marijuana In The U.S.? (Forbes)

• Indiana Democratic Party Backs Marijuana Legalization And Pledges 2022 Reform Push (Marijuana Moment)

• New York Senator Files Bill To Extend Marijuana Equity Benefits To Transgender And Non-Binary People (Marijuana Moment)

• Straws Lined with THC Could Transform Edibles Industry (High Times)

• Bipartisan Wisconsin Lawmakers Unveil Marijuana Decriminalization Bill (Marijuana Moment)

• New study shows no increase in car crash injuries after marijuana legalized (Vancouver Sun)

• Canadian Groups Gives Free Weed And Edibles To Fight Opioid Abuse (High Times)

• Marijuana Legalization Attitudes Vary Significantly Within Partisan Coalitions, Pew Survey Shows (Marijuana Moment)

• Creating a better cannabis cultivation facility while strengthening relationships with third-party testing labs (Marijuana Business Daily)

• Sturdy Hemp Structures Could be the Future Eco-Building (High Times)

• Using cannabis in pregnancy linked to aggression and anxiety in children, a study suggests (CNN)

• Study: Scarification of cannabis seeds, certain disinfectants boost germination rates (Marijuana Business Daily)

LSD

• MindMed Launches Study of Low-Dose LSD Effects on Sleep and Cognitive Measures (Psilocybin Alpha)

• Up, Up and Away: The Trippy Tales Behind ‘Flying Over Sunset’ (The New York Times)

• Is LSD Safe - Latest Research Findings (Drug Science)

• The LSD Comedown: Navigating the After Effects of Acid (DoubleBlind)

Magic Mushrooms

• Bill on magic mushrooms aims to make Pa. a national leader in psychedelic research (The Philadelphia Inquirer)

• NYC Subways Ban Marijuana And Psychedelic Mushroom Ads (Marijuana Moment)

• Magic Mushrooms, A Love Story (The New Yorker)

• PharmaTher Announces Positive Research Results for Psilocybin Microneedle Patch (Psilocybin Alpha)

• Tryp Therapeutics Provides Update on Clinical Hold for Phase 2a Study for Eating Disorders (Yahoo!)

• TheraPsil and Imperial College London, McGill University Partner on Psilocybin Study (Truffle Report)

• Red Light Holland Psilocybin Truffles, Sold in The Netherlands, Complete First Evaluation Under a Health Canada Approved cGMP Laboratory (Psilocybin Alpha)

• Another Life: Foraging for mushrooms and natural psychedelics (The Irish Times)

MDMA

• World's 'Strongest-Ever' Ecstasy Pill Found in English Nightclub (VICE)

DMT

• Algernon Announces Positive Feedback on its Planned Phase 1/2a DMT Human Stroke Study (Yahoo!)

• Discussions With FDA Provide Guidance for Phase IIb Clinical Trial Design for DMT-Assisted Therapy for Major Depressive Disorder (Psilocybin Alpha)

Ayahuasca

• Is This Phoenix Pastor a Spiritual Shaman or an Ayahuasca Kingpin — or Both? (Phoenix New Times)

• Ron White’s strange ayahuasca experience, as described on JRE. (Ceng News)

5-MeO-DMT

• Mike Tyson ‘died’ while tripping on psychedelic toad venom (New York Post)

• Biomind Labs Completes Development of a Thermosensitive Nasal Gel Pharmaceutical Dosage Form (Business Wire)

Novel Psychoactive Substances

• New Psychedelic Molecules: What’s in Development? (Truffle Report)

• New Psychedelic Molecules Part II: Key Industry Players (Truffle Report)

• Researchers train computers to predict the next designer drugs (ScienceDaily)

• BetterLife Pharma says pharmacology data on second-generation LSD derivative confirms its projected non-hallucinogenic property (Proactive Investors)

Ketamine

• Michael J. Fox Foundation Grant Will Fund First Clinical Trial of Ketamine to Treat Depression in People with Parkinson’s Disease (Yale School of Medicine)

• Warning of ‘wild west’ in depression treatment as UK clinics offer ketamine (The Guardian)

• Bexson Biomedical Announces Expansion to Treat Major Depression with Wearable Ketamine Formulation (PR Newswire)

• Silo Pharma and Strategic Partner Zylo Therapeutics Begin Development Process for Novel Ketamine Loaded Z-Pods (Psilocybin Alpha)

DXM

• Teenagers are ‘robotripping’ in the pursuit of cheap highs, again (Screenshot Media!)

Miscellaneous

• Jon Hopkins’s Psychedelic Journey to a New Way of Creating Music (The New York Times)

• "Aharon said it was healing:" How psychedelic therapy was undermined by abuse (Inverse)

• Psychedelics Use Associated With 55 Percent Decrease In Daily Opioid Consumption, Study Finds (Marijuana Moment)

• Horizons Conference Reconvenes in NYC to Connect Psychedelic Communities (Lucid News)

• New Non-Profit Supports Groundbreaking HPPD or ‘Acid Flashback’ Research (Truffle Report)

• Inside The Race To Create A Two-Hour Psychedelic Therapy Experience (Forbes)

• Psychedelics Help Heal Childhood Trauma, Study Finds (Benzinga)

• Psychedelic Bypassing: When Avoidance is Mistaken for Healing (Psychedelics Today)

• Canadian Biotech Known For Psilocybin And Cannabinoid-Based Medicines In FDA Phase 3 Trial For Bucillamine-Based Oral Covid Treatment (Forbes)

• Three Decades of Drug Policy Reform Work (Open Society Foundations)

• A Close Reading of the QAnon Shaman’s Conspiracy Manifesto (Lit Hub)

• Naropa University Announces Psychedelic-Assisted Therapies Certificate (Tricycle)

• A New Psychedelic Organization is Merging Shamanism and Science (Lucid News)

• The Serotonin 5-HT2A Receptor: From Mice to Humans (Psychedelic Science Review)

• Animals That Eat Psychedelics and Enjoy the Trip (Psychedelic Spotlight)

• CaaMTech Teams Up With University of Wyoming to Study Psychedelics as Treatments for Addiction (Psilocybin Alpha)

• MYND Diagnostics Commences Clinical Research on Alzheimer’s Disease (Psilocybin Alpha)

• Letting people test their drugs will reduce the number of needless deaths (The Independent)

• The History of Psychedelics: An ancient tradition (Canex)

• MYND Diagnostics Commences Clinical Research on Multiple Sclerosis Biomarker Test (Psilocybin Alpha)

Think Wilder is reader-supported. If you enjoyed this week’s update, please consider helping out by becoming a patron, making a one-time donation, or sharing this post with a friend. Thank you for your support.

Disclaimer: "This Week in Psychedelics" does not censor or analyze the news links presented here. The purpose of this column is solely to catalog how psychedelics are presented by the mass media, which includes everything from the latest scientific research to misinformation.

This Week in Psychedelics - 10.8.21

Cannabis

• Philadelphia Will Vote On Marijuana Referendum Calling For Statewide Legalization Next Month (Marijuana Moment)

• Top Mexican Senator Lays Out Next Steps For National Marijuana Legalization (Marijuana Moment)

• Nevada: New Marijuana Laws Took Effect This Month (NORML)

• Portugal Delays Recreational Cannabis Bills as Luxembourg Also Signals Delay (High Times)

• New York: Regulators Approve Patients’ Access to Medical Cannabis Flower (NORML)

• NBA Won’t Randomly Drug Test Players For Marijuana For Another Season, League Announces (Marijuana Moment)

• Lung Injuries Tied To Contaminated Vapes Were Less Common In States With Legal Marijuana And Homegrow, Study Finds (Marijuana Moment)

• California Legalizes Smokable Hemp and Food Sales in Historic Bill (High Times)

• Preconception cannabis use linked to an increased risk of postpartum depression (PsyPost)

• More Than A Dozen Ohio Cities Will Vote On Marijuana Decriminalization Ballot Measures Next Month (Marijuana Moment)

• CBGA More Effective For Seizures Than CBD, Study of Mice Finds (High Times)

• Study: Cannabis Use Disorder Diagnosis Associated with Greater Risk of COVID Breakthrough Infections — NORML Responds (NORML)

• Bipartisan Pennsylvania Senators Unveil Marijuana Legalization Bill Amid Whirlwind Of Reform Efforts In The State (Marijuana Moment)

• Oklahoma Activists File Marijuana Legalization And Medical Cannabis Reform Initiatives For 2022 Ballot (Marijuana Moment)

LSD

• Inside the World’s Largest Collection of Acid Tabs (DoubleBlind)

• Acid Communism (Daniel Pinchbeck)

Magic Mushrooms

• GOP Pennsylvania Lawmaker Files Psilocybin Research Bill For Veterans And First Responders (Marijuana Moment)

• Denver may ease magic mushrooms laws further two years after decriminalization (The Denver Post)

• Is Denver’s Psilocybin Decriminalization Having an Impact? (Filter)

• Psychedelic drug changes the emotional state of people listening to music (News-Medical.net)

• "Homebrew" Psilocybin Created By Scientists Using "Widely Available" Materials (IFLScience)

• Mydecine To Supply Lead Drug Candidate, MYCO-001, for Multi-Site NIDA Grant-Funded Smoking Cessation Study Lead by Dr. Matthew Johnson (Mydecine)

• Psygen Announces use of Psilocybin in Human Trial and Provides Update on IP Portfolio (Psilocybin Alpha)

• Psyched Wellness Announces Commencement of Next Pre-Clinical Study on AME-1 (Psilocybin Alpha)

MDMA

• Why You Vom When You’re Coming Up On MDMA (VICE)

• MDMA-assisted psychotherapy associated with sleep improvements among PTSD patients (PsyPost)

Peyote

• Santa Cruz Removes Peyote And Other Mescaline-Containing Cacti From Psychedelics Decriminalization Law (Marijuana Moment)

Novel Psychoactive Substances

• Psychedelic Capital: Novel Psychedelic Molecules (Truffle Report)

Ketamine

• Recreational ketamine use has increased in recent years, but remains rare (Medical Xpress)

• PharmaTher Initiates Phase 2 Clinical Trial of Ketamine for the Treatment of Parkinson’s Disease (Psilocybin Alpha)

Miscellaneous

• Seattle Becomes Largest U.S. City To Decriminalize Psychedelics (Marijuana Moment)

• Arcata, California Decriminalizes Psychedelics (Truffle Report)

• The Psychedelics Industry Could Offer a Whole New Approach to Work (Rolling Stone)

• Will Smith Recalls Life-Changing Psychedelic Experiences in New Book (High Times)

• PSYCH Publishes Third Edition of The Psychedelics as Medicine Report (PR Newswire)

• Toronto’s Bid to Decriminalize Drugs Hangs in the Balance (Filter)

• The Need for New Psychedelic Compounds (Psychology Today)

• Risks of Serotonin Syndrome when Combining Psychedelics with Antidepressants (Chacruna)

• The 'Psychedelic Renaissance' Is Entirely About Corporate Greed (Caitlin Johnstone)

• Becoming a Yes-Sayer: Psychedelics, Nietzsche, and the Affirmation of Life (Sam Woolfe)

• Will Psychedelic Companies Embrace Indigenous Reciprocity? (Lucid News)

• What Is Hallucinogen-Persisting Perception Disorder (HPPD)? (PsychCentral)

• Anima Mundi: Psychedelics and The Ensouled Earth (Psychedelics Today)

• Ensuring Equity in Psychedelic Science and Businesses (Truffle Report)

• Death and psychedelics: How science is reviving this ancient connection (Leafly)

• DoubleBlind Claims Its Ad Was the ‘First-Ever’ U.S. Psychedelic Destigmatization Campaign — It Wasn’t (Psymposia)

• Psychedelic-Induced Psychological Flexibility Can Reduce Racial Trauma (Truffle Report)

• Tryp Therapeutics Announces Collaboration with Researchers at the University of Wisconsin-Madison (Psilocybin Alpha)

• Psychedelics and Mental Health Therapy in Colorado: DORA and Potential Regulatory Response (JD Supra)

• Psychedelics and Perception Part 2: The First Era of Research (Psychedelic Science Review)

• It’s one big mistake (New Amsterdam Psychedelic Law)

• Madison Margolin Sounds Off on Mainstreaming of Cannabis and Psychedelics Cultures (CelebStoner)

• Numinus Upgrades Psychedelics Lab to Increase Research Service Capabilities (PR Newswire)

Think Wilder is reader-supported. If you enjoyed this week’s update, please consider helping out by becoming a patron, making a one-time donation, or sharing this post with a friend. Thank you for your support.

Disclaimer: "This Week in Psychedelics" does not censor or analyze the news links presented here. The purpose of this column is solely to catalog how psychedelics are presented by the mass media, which includes everything from the latest scientific research to misinformation.

This Week in Psychedelics - 6.11.21

Cannabis

• Nevada: Governor Signs Bill into Law Regulating Cannabis Consumption Lounges (NORML)

• Senate Votes to Legalize Recreational Marijuana in Conn. (NBC Connecticut)

• Washington state offers ‘joints for jabs’ to boost vaccination rates (The Guardian)

• Louisiana lawmakers pass bill to decriminalize marijuana (The Hill)

• Biden Administration Wants to Uphold Ban on Adult-Use Cannabis Sales in DC (MERRY JANE)

• Testing People For Marijuana Impairment Based On THC Levels Is ‘Not Reliable,’ Federally Funded Study Finds (Marijuana Moment)

• Study: Enactment of Adult-Use Marijuana Laws Doesn’t Encourage Drugged Driving Behavior (NORML)

• Medical Cannabis Users Are More Likely to Cut Back on Cigarettes, Study Finds (MERRY JANE)

• NFL Funds Marijuana Research As Federal Prohibition ‘Adversely’ Impacts Studies Into Opioid Alternative For Players (Marijuana Moment)

• Virginia: Marijuana Arrests Fall Dramatically Following Enactment of 2020 Decriminalization Law (NORML)

• Bill Would Finally Let Researchers Obtain Marijuana From Dispensaries (Filter)

• LA Is Literally the Worst Place to Buy Legal Weed, Thanks to Exorbitant Sales Taxes (MERRY JANE)

LSD

• Susi’s Tram Ride: Recognizing the First Woman to Take LSD (Chacruna)

• Deepak Chopra did LSD for the first time in a lab and felt his consciousness shift while staring at a photo of Mother Teresa (Insider)

• Blotter paper part of LSD mixture, must be weighed too (The Times of India)

• LSD and the Anarchic Brain (Psychedelic Science Review)

• LSD for Bipolar Disorder: Is LSD the Answer? (The Third Wave)

Magic Mushrooms

• Silo Pharma Announces Collaboration with University California San Francisco to study Psilocybin as an Anti-Inflammatory agent in Parkinson’s and Bipolar Patients (Psilocybin Alpha)

• Psilocybin Oral Strips: Benefits and Drawbacks (Truffle Report)

• Mydecine Discovers Over 40 Groundbreaking Potential Pharmacologically Active Novel Compounds in Mushrooms (Psilocybin Alpha)

MDMA

• Pill-iD App Lets Users Scan MDMA Pills To See What They Contain (LADbible)

• MDMA soaring in popularity in New Zealand, making its way into high schools (Newshub)

• MDMA, Water, Seizures, and Death: Interview with Gabriel Kearns, M.D. and Founder of Elevation Chemicals (Psychedelic Times)

Ayahuasca

• Is Ayahuasca Legal? (DoubleBlind)

5-MeO-DMT

• A hallucinogenic toad in peril (High Country News)

Iboga

• Iboga Conservation (Chacruna)

Nitrous Oxide

• Can Laughing Gas (Nitrous Oxide) Help People With Treatment-Resistant Depression? (Forbes)

Ketamine

• Colorado bill to restrict ketamine use outside of hospitals close to passing (Colorado Newsline)

• Deaths Resulting from Ketamine Injection Rare, Study Indicates (JEMS)

Miscellaneous

• Connecticut Governor Signs Psychedelics Study Measure As He Awaits Marijuana Legalization Bill (Marijuana Moment)

• The FBI Secretly Ran an Encrypted Messaging Service To Conduct the Same Old Drug War Stings (Reason)

• Aphrodite Health Is Here To Shift The Narrative: The First Psychedelics Company ‘For Women, By Women’ (Forbes)

• Poll Shows Huge Public Opposition to “War on Drugs,” After 50 Years (Filter)

• Seattle City Council Signs Letter Proposing Psychedelic Use in Opioid Addiction Treatment (Truffle Report)

• Field Trip Health Ltd. Applies to List Its Common Shares on the NASDAQ Stock Market (Psilocybin Alpha)

• Over One Third of US Voters Know Psychedelics Have Valid Medical Use, Poll Says (MERRY JANE)

• Psychedelics For Frontline Clinicians With Covid-Related Burnout? A Study Is Looking Into It (Forbes)

• Accountability & Transformative Justice in the Psychedelic Space: A Roadmap for Change (Psychedelics Today)

• Study Links Hallucinogen Use to Emotional Dysregulation, Risk Taking Among Youth (Psychedelic News Wire)

• Life Sciences Announces Launch of Initial Public Offering (Psilocybin Alpha)

• Are Psychedelics the Next Big Cure? (Good Housekeeping)

• Is Absinthe an Hallucinogen? Debunking the Green Fairy (Truffle Report)

• Tolerance, Tachyphylaxis, and Psychedelic Drug Action (Psychedelic Science Review)

• Basics for Tripping in Nature (Maps of the Mind)

• Psychedelic Cartoons: Through the Decades (Reality Sandwich)

Think Wilder is reader-supported. If you enjoyed this week’s update, please consider helping out by becoming a patron, making a one-time donation, or sharing this post with a friend. Thank you for your support.

Disclaimer: "This Week in Psychedelics" does not censor or analyze the news links presented here. The purpose of this column is solely to catalog how psychedelics are presented by the mass media, which includes everything from the latest scientific research to misinformation.

This Week in Psychedelics - 5.21.21

Cannabis

• Alabama Governor Signs Medical Marijuana Legalization Bill (Marijuana Moment)

• Montana Governor Signs Marijuana Legalization Implementation Bill (Marijuana Moment)

• Colorado Governor Signs Bill To Double Marijuana Possession Limit And Calls For Pardons Review (Marijuana Moment)

• Mississippi Supreme Court Overturns Medical Marijuana Legalization Ballot That Voters Approved (Marijuana Moment)

• Colorado bans hemp-derived delta-8 THC (Marijuana Business Daily)

• Minnesota: Lawmakers Vote to Legalize Medical Cannabis Flower (NORML)

• Texas Medical Marijuana Expansion Bill Moves Forward In Senate After Initially Stalling (Marijuana Moment)

• Louisiana Marijuana Legalization Effort Stalls After House Rejects Complementary Tax Proposal (Marijuana Moment)

• The Impact of Specific Genes on Cannabis Use Disorder (Psychedelic Science Review)

LSD

• Acid test: scientists show how LSD opens doors of perception (The Guardian)

• The Untold Story of the CIA’s MK Ultra: A Conversation with Stephen Kinzer (Los Angeles Review of Books)

• MindMed Receives FDA Type C Meeting Response for Project Lucy Phase 2b Clinical Trial (Psilocybin Alpha)

Magic Mushrooms

• A single dose of psilocybin has a lasting therapeutic effect on migraine headache, according to a new placebo-controlled study (PsyPost)

• Kristen Bell Tried Hallucinogenic Mushrooms to Help Manage Her Depression (People)

• Wake Network Successfully Completes First Legal Importation of Psilocybin Mushrooms into the U.S. (Lucid News)

• Cybin Granted IRB Approval for Phase II Clinical Trials of its Sublingual Psilocybin Formulation for the Treatment of Major Depressive Disorder (Psilocybin Alpha)

MDMA

• FDA Clears Researchers To Study MDMA Use By Therapists Being Trained In Psychedelic Medicine (Marijuana Moment)

• How MDMA, Octopuses, and Gül Dölen Reopen Minds (Chacruna)

• Narcos Scotland: The 90s rave culture in Scotland brought a deadly new trend with Ecstasy (Scottish Daily Record)

DMT

• Algernon Pharmaceuticals Receives Positive Feedback from U.S. FDA for Psychedelic Drug DMT Clinical Research Program for Stroke (Psilocybin Alpha)

• Entheon Biomedical Announces DMT Drug Supply Agreement with Ofichem Group (Psilocybin Alpha)

Ayahuasca

• Controversies on the Environmental Legislation on Ayahuasca in Brazil (Chacruna)

• Can Ayahuasca Help Us Communicate with the Souls of the Dead? (DoubleBlind)

Mescaline

• MindMed Announces the Approval of Mescaline Study (Psilocybin Alpha)

Peyote

• Psychedelics Advocates And Indigenous Groups Split On Decriminalizing Peyote Cactus (Marijuana Moment)

• Is Peyote the same as mescaline?: A Cultural History (Chacruna)

Salvia Divinorum

• This DEA ‘medication of concern’ may have health benefits (MD Linx)

Synthetic Cannabinoids

• Why Big Pharma Loves The Power Of Synthetic Cannabinoids (The Fresh Toast)

Ketamine

• Lamar Odom says he is using ketamine to stay sober (Page Six)

• PharmaTher Announces FDA Approval of Ketamine IND In The Treatment of Parkinson’s Disease (Psilocybin Alpha)

Miscellaneous

• California’s Psychedelic Decriminalization Bill Heads to Senate Floor (Truffle Report)

• Texas Senate Advances Bill To Study Healing Potential Of Psychedelics Like Psilocybin and MDMA (Marijuana Moment)

• Psychedelic Drugs Will Follow Pot’s Path to Legalization (Bloomberg)

• The future of psychedelic science (Imperial College London)

• Use of hallucinogens linked to risk seeking, emotional dysregulation in youth and college students (PsyPost)

• Confronting Inequity and Seeking Social Justice in the Psychedelic Movement (Chacruna)

• The Jacarezinho Massacre and Lethal Drug Policy Enforcement in Brazil (Filter)

• IPI: The Top Recommended Psychedelic Therapy Training (The Third Wave)

• Imagine Psychedelic Dinosaurs Tripping Daily (Reality Sandwich)

• An Investor Looks at Drug Development Strategies of Top Psychedelic Companies (Lucid News)

• Psychedelic-Assisted Psychotherapy: Reshaping Perspectives and Guiding Transformation (Psychedelic Times)

• Do Animals and Psychedelics Go Together? (Reality Sandwich)

Think Wilder is reader-supported. If you enjoyed this week’s update, please consider helping out by becoming a patron, making a one-time donation, or sharing this post with a friend. Thank you for your support.

Disclaimer: "This Week in Psychedelics" does not censor or analyze the news links presented here. The purpose of this column is solely to catalog how psychedelics are presented by the mass media, which includes everything from the latest scientific research to misinformation.

This Week in Psychedelics - 4.23.21

Cannabis

• Schumer Celebrates 4/20 Marijuana Holiday On Senate Floor (Marijuana Moment)

• US House Passes Bill To Normalize Adult-Use Cannabis Commerce (NORML)

• Virginia Governor Signs Marijuana Legalization Bill In Ceremonial Event—Even Though It’s Already Enacted (Marijuana Moment)

• New Jersey Supreme Court Rules Company Must Cover Employee's Medical Marijuana Costs (MERRY JANE)

• Nine In Ten Americans Support Legalizing Marijuana For Recreational Or Medical Use, New Pew Poll Finds (Marijuana Moment)

• Florida Supreme Court Kills 2022 Marijuana Legalization Initiative That Hundreds Of Thousands Had Signed (Marijuana Moment)

• Border weed: How the hometown of tater tots became a cannabis capital (Politico)

• Louisiana Lawmakers Approve Bill To Legalize Medical Marijuana Flower For Patients (Marijuana Moment)

• Veterans Medical Marijuana Safe Harbor Act Reintroduced (NORML)

• Minnesota Marijuana Legalization Bill Clears Eighth Committee On Route To The House Floor (Marijuana Moment)

• Two-thirds of La. voters support legalizing marijuana; state lawmakers on both sides of the aisle eye legalization (WAFB)

LSD

• Today Is Bicycle Day, Which Isn’t Quite What You Think (Mother Jones)

• LSD Side-Effects: Risks To Be Aware of When Consuming LSD (The Third Wave)

Magic Mushrooms

• Oregon’s and Compass’s Opposite Approaches to Psilocybin Therapy Should Coexist, Says Initiator of Measure 109 (Chacruna)

• Revive Therapeutics Announces Successful Research Results for Oral Thin Film Psilocybin and Filing of U.S. Provisional Patent Application (Psilocybin Alpha)

MDMA

• MDMA and magic mushrooms reconsidered for rescheduling by Therapeutic Goods Administration (The Canberra Times)

• This is why sex on MDMA feels so good, according to experts (Gentside UK)

Ayahuasca

• Advocacy Group Aims to Decriminalize Ayahuasca in Portland (Willamette Week)

• Some Vermonters Turn to Ayahuasca as a 'Last Resort' to Heal Their Bodies and Minds (Seven Days)

5-MeO-DMT

• Researchers In Europe, U.S. Team Up To Produce First Ever 5-MeO-DMT Psychedelic Training Program (Forbes)

• Toad Conservation (Chacruna)

Peyote

• Hello, Religious Privilege is Good and Here's Why (Patheos)

Novel Psychoactive Substances

• 18-MC Has Unique Brain Functions and Mechanisms (Psychedelic Science Review)

Synthetic Cannabinoids

• Study explores synthetic cannabinoid for cancer-related anorexia (Outsourcing-Pharma.com)

Ketamine

• PharmaTher Announces Submission of IND Application with the FDA for Phase 2 Clinical Trial Evaluating Ketamine in the Treatment of Parkinson’s Disease (Psilocybin Alpha)

• Ketamine Infusion: How Ketamine Can Treat Depression, Anxiety, PTSD, and More (DoubleBlind)

PCP

• State's medical expert to grand jury: 'Police didn't kill Daniel Prude' (WXXI News)

Miscellaneous

• Norway opposition torpedoes plan to decriminalise drug use (France 24)

• Washington State Lawmakers Downgrade Proposed Drug Possession Penalties Ahead Of House Floor Vote (Marijuana Moment)

• Biden Is Allegedly Planning to Double Down on Trump's Prohibitionist Drug Policies (MERRY JANE)

• MindMed To Commence Trading on Nasdaq (Psilocybin Alpha)

• The “Equity Elephant”: Why Psychedelic Mutualism and Cooperatives are Crucial for an Accessible Future (Psychedelics Today)

• Jewish psychedelics movement blasts off with first-ever conference (The Times of Israel)

• ATAI Nasdaq IPO Plans Announced (Truffle Report)

• Researchers Slam Drug War At Federally Hosted Psychedelics Event (Marijuana Moment)

• There’s a Land Grab for Psychedelic Patents: Here’s What We Can Do About It (Psychedelic Times)

• You're Not Hallucinating: Black People Are Being Left Out of the Psychedelic Renaissance (The Root)

• People who regularly use psychoactive substances experienced negative impacts during COVID-19 (News-Medical.net)

• Most Canadians not ready to expand drug legalization beyond cannabis: poll (Coast Reporter)

• Extinction Rebellion founder says psychedelic drugs 'helped start environmental movement' (Wales Online)

• Silo Wellness Announces Five New Psychedelic Wellness Retreats in Jamaica (Psilocybin Alpha)

• Psychedelic Experience launches new website to help navigate the world of psychedelics (PR Newswire)

• The Overlap Between Kink/BDSM and Psychedelics (Chacruna)

• Cybin Demonstrates Proof of Concept of Its Deuterated Tryptamines for the Treatment of Depression and Addiction (Psilocybin Alpha)

• Michael Pollan: A Catalyst to the Psychedelic Renaissance (The Third Wave)

• If You're Going to Solo Trip On Psychedelics, Bear This in Mind (VICE)

Think Wilder is reader-supported. If you enjoyed this week’s update, please consider helping out by becoming a patron, making a one-time donation, or sharing this post with a friend. Thank you for your support.

Disclaimer: "This Week in Psychedelics" does not censor or analyze the news links presented here. The purpose of this column is solely to catalog how psychedelics are presented by the mass media, which includes everything from the latest scientific research to misinformation.